A rational approach to 5-aminosalicylic acid therapy in ulcerative colitis.
Miner
P B
PB
Department of Medicine, University of Kansas Medical Center, Kansas City.
Peppercorn
M A
MA
Targan
S R
SR
D000284:Administration, Oral; D000285:Administration, Rectal; D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000627:therapeutic use; D003663:Decision Trees; D004359:Drug Therapy, Combination; D016099:Endoscopy, Gastrointestinal; D004733:Enema; D005260:Female; D005440:Fluid Therapy; D006801:Humans; D008297:Male; D019804:Mesalamine; D010288:Parenteral Nutrition; D012720:Severity of Illness Index; D013256:Steroids / Q000627:therapeutic use; D013488:Suppositories
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D013256:Steroids; D013488:Suppositories; D019804:Mesalamine